Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer.
Journal: The New England journal of medicine
Published: May 27, 2026
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.
Journal: JCO precision oncology
Published: April 22, 2026
NRG-GI007: Phase 1 Study of OBP-301, An Oncolytic Virus, and Definitive Chemoradiation in Locally Advanced Esophageal Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: March 30, 2026
Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: preclinical investigations to a phase I clinical trial (NCT06623396).
Journal: Journal for immunotherapy of cancer
Published: August 27, 2025
Genomic and clinical parallels between US and Japanese gastric cancers: a propensity score-matched cohort study.
Journal: The British journal of surgery
Published: July 21, 2025
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 31, 2025
Nonoperative Management of Mismatch Repair-Deficient Tumors.
Journal: The New England journal of medicine
Published: April 28, 2025
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study.
Journal: The Lancet. Oncology
Published: March 24, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 31, 2024
The efficacy of plasma exosomal miRNAs as predictive biomarkers for PD-1 blockade plus chemotherapy in gastric cancer.
Journal: Translational cancer research
Published: November 01, 2024
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 22, 2024
Last Updated: 09/26/2026